APA (7th ed.) Citation

YH, C., YC, L., SH, C., SY, F., TP, C., CH, C., . . . HY, H. (2025). Discovery of a novel C2-functionalized chromen-4-one scaffold for the development of p38α MAPK signaling inhibitors to mitigate neutrophilic inflammatory responses. Biochemical pharmacology, 235, 116806. https://doi.org/10.1016/j.bcp.2025.116806

Chicago Style (17th ed.) Citation

YH, Chang, Lee YC, Chen SH, Fang SY, Cheng TP, Chi CH, Tsai KC, Chen PJ, and Hung HY. "Discovery of a Novel C2-functionalized Chromen-4-one Scaffold for the Development of P38α MAPK Signaling Inhibitors to Mitigate Neutrophilic Inflammatory Responses." Biochemical Pharmacology 235 (2025): 116806. https://doi.org/10.1016/j.bcp.2025.116806.

MLA (9th ed.) Citation

YH, Chang, et al. "Discovery of a Novel C2-functionalized Chromen-4-one Scaffold for the Development of P38α MAPK Signaling Inhibitors to Mitigate Neutrophilic Inflammatory Responses." Biochemical Pharmacology, vol. 235, 2025, p. 116806, https://doi.org/10.1016/j.bcp.2025.116806.